1 - 25 of 62 results for author:"Aasly J." in Literature citations
Results Customize
› Repeat search in UniProtKB (12)
| Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Allen M., Zou F., Chai H.S., Younkin C.S., Miles R., Nair A.A., Crook J.E., Pankratz V.S., Carrasquillo M.M., Rowley C.N. et al. Mol Neurodegener 7:13-13(2012) · Mapped (5) |
| Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Rademakers R., Baker M., Nicholson A.M., Rutherford N.J., Finch N., Soto-Ortolaza A., Lash J., Wider C., Wojtas A., DeJesus-Hernandez M. et al. |
| Cerebrospinal fluid amyloid beta and tau in LRRK2 mutation carriers. Aasly J.O., Shi M., Sossi V., Stewart T., Johansen K.K., Wszolek Z.K., Uitti R.J., Hasegawa K., Yokoyama T., Zabetian C.P. et al. Neurology 78:55-61(2012) · Mapped (16) |
| Translation initiator EIF4G1 mutations in familial Parkinson disease. Chartier-Harlin M.C., Dachsel J.C., Vilarino-Guell C., Lincoln S.J., Lepretre F., Hulihan M.M., Kachergus J., Milnerwood A.J., Tapia L., Song M.S. et al. Am. J. Hum. Genet. 89:398-406(2011) · UniProtKB (1) · Mapped (9) |
| Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium Lancet Neurol 10:898-908(2011) · Mapped (4) |
| Leukoencephalopathy with brainstem and spinal cord involvement caused by a novel mutation in the DARS2 gene. Tzoulis C., Tran G.T., Gjerde I.O., Aasly J., Neckelmann G., Rydland J., Varga V., Wadel-Andersen P., Bindoff L.A. J. Neurol. 259:292-296(2012) · Mapped (4) |
| Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease. Genetic Epidemiology of Parkinson's Disease Consortium Neurobiol. Aging 32:2108.e1-5(2011) · Mapped (3) |
| VPS35 mutations in Parkinson disease. Vilarino-Guell C., Wider C., Ross O.A., Dachsel J.C., Kachergus J.M., Lincoln S.J., Soto-Ortolaza A.I., Cobb S.A., Wilhoite G.J., Bacon J.A. et al. Am. J. Hum. Genet. 89:162-167(2011) · UniProtKB (2) · Mapped (2) |
| Death-associated protein kinase 1 variation and Parkinson's disease. Dachsel J.C., Wider C., Vilarino-Guell C., Aasly J.O., Rajput A., Rajput A.H., Lynch T., Craig D., Krygowska-Wajs A., Jasinska-Myga B. et al. Eur. J. Neurol. 18:1090-1093(2011) · Mapped (10) |
| Subclinical signs in LRRK2 mutation carriers. Johansen K.K., White L.R., Farrer M.J., Aasly J.O. Parkinsonism Relat. Disord. 17:528-532(2011) · Mapped (4) |
| Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosis. Tomiyasu A., Nakamura M., Ichiba M., Ueno S., Saiki S., Morimoto M., Kobal J., Kageyama Y., Inui T., Wakabayashi K. et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B:620-631(2011) · Mapped (2) |
| Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V. et al. Nat. Genet. 43:429-435(2011) · Mapped (15) |
| Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium Ann. Neurol. 69:778-792(2011) · Mapped (13) |
| Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. Carrasquillo M.M., Belbin O., Hunter T.A., Ma L., Bisceglio G.D., Zou F., Crook J.E., Pankratz V.S., Sando S.B., Aasly J.O. et al. J. Alzheimers Dis. 24:751-758(2011) · Mapped (4) |
| SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study. Wider C., Vilarino-Guell C., Heckman M.G., Jasinska-Myga B., Ortolaza-Soto A.I., Diehl N.N., Crook J.E., Cobb S.A., Bacon J.A., Aasly J.O. et al. Eur. J. Neurol. 18:876-881(2011) · Mapped (17) |
| Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2. Mortiboys H., Johansen K.K., Aasly J.O., Bandmann O. Neurology 75:2017-2020(2010) · Mapped (4) |
| Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Sossi V., de la Fuente-Fernandez R., Nandhagopal R., Schulzer M., McKenzie J., Ruth T.J., Aasly J.O., Farrer M.J., Wszolek Z.K., Stoessl J.A. Mov. Disord. 25:2717-2723(2010) · Mapped (4) |
| Mitochondrial translation initiation factor 3 polymorphism and Parkinson's disease. Behrouz B., Vilarino-Guell C., Heckman M.G., Soto-Ortolaza A.I., Aasly J.O., Sando S., Lynch T., Craig D., Uitti R.J., Wszolek Z.K. et al. Neurosci. Lett. 486:228-230(2010) · Mapped (1) |
| Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease. Aasly J.O., Vilarino-Guell C., Dachsel J.C., Webber P.J., West A.B., Haugarvoll K., Johansen K.K., Toft M., Nutt J.G., Payami H. et al. Mov. Disord. 25:2156-2163(2010) · Mapped (5) |
| A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Kruger R., Sharma M., Riess O., Gasser T., Van Broeckhoven C., Theuns J., Aasly J., Annesi G., Bentivoglio A.R., Brice A. et al. Neurobiol. Aging 32:548.e9-18(2011) · Mapped (2) |
| Association of the MAPT locus with Parkinson's disease. Wider C., Vilarino-Guell C., Jasinska-Myga B., Heckman M.G., Soto-Ortolaza A.I., Cobb S.A., Aasly J.O., Gibson J.M., Lynch T., Uitti R.J. et al. Eur. J. Neurol. 17:483-486(2010) · Mapped (6) |
| Metabolomic profiling in LRRK2-related Parkinson's disease. Johansen K.K., Wang L., Aasly J.O., White L.R., Matson W.R., Henchcliffe C., Beal M.F., Bogdanov M. PLoS ONE 4:e7551-e7551(2009) · Mapped (4) |
| Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., Bar-Shira A., Berg D., Bras J., Brice A. et al. N. Engl. J. Med. 361:1651-1661(2009) · UniProtKB (1) |
| GCH1 in early-onset Parkinson's disease. Cobb S.A., Wider C., Ross O.A., Mata I.F., Adler C.H., Rajput A., Rajput A.H., Wu R.M., Hauser R., Josephs K.A. et al. Mov. Disord. 24:2070-2075(2009) · Mapped (5) |
| LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Vilarino-Guell C., Ross O.A., Wider C., Jasinska-Myga B., Cobb S.A., Soto-Ortolaza A.I., Kachergus J.M., Keeling B.H., Dachsel J.C., Melrose H.L. et al. Parkinsonism Relat. Disord. 16:109-111(2010) · Mapped (1) |